Tetrapyrroles and derivatives
Abcam DPDPE, delta opioid receptor agonist, 1MG
MW 645.79 g/mol, Purity >95%. Potent and selective δ opioid receptor agonist (Ki values are 14, >1000 and >1000 nM for opioid receptor subtypes δ, κ and μ, respectively). Centrally active following systemic administration.
The product is subject to the following: Abcam Restricted Use Statement
Abcam SB-277011-A dihydrochloride, D3 antagonist, 5MG
MW 511.5 Da, Purity >98%. Potent, highly selective D3 receptor antagonist (pKi = 7.95 at hD3 receptors). Exhibits over 100-fold selectivity over D2 receptors. Blood-brain barrier (BBB) permeable. Diminishes nicotine, cocaine and alcohol self-administration. Interferes with mechanisms of drug-taking and reinstatement of drug-taking behaviours.
The product is subject to the following: Abcam Restricted Use Statement
Abcam (R,S)-CPP, NMDA antagonist, 10MG
MW 252.2 Da. Potent, competitive NMDA antagonist. See separate isomer (ab120159). Also available in simple stock solutions (ab146720) - add 1 ml of water to get an exact, ready-to-use concentration.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Flupenthi x ol dihydrochloride, Non-selective dopamine receptor antagonist, 50MG
MW 507.4 Da, Purity >99%. Non-selective antagonist at D₁ and D₂ receptors. Antagonist at dopamine (D₁-D₅), serotonin (5-HT₂), adrenergic (α₁) and histamine (H₁) receptors. Antipsychotic properties in vivo.
The product is subject to the following: Abcam Restricted Use Statement
Abcam PNU 120596, Positive allosteric modulator for alpha7 nicotinic acetylcholine receptors, 50MG
MW 311.72 Da, Purity >99%. Competitive, type II positive allosteric modulator for α7nAChR (EC₅₀ = 216 nM). Increases potency of nicotinic agonists. No effect on α4β2, α3β4 and α9α10 nAChRs. Active in vivo.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Rotigotine hydrochloride, Dopamine receptor agonist, 10MG
MW 351.93 g/mol, Purity >99%. Dopamine receptor agonist. High affinity for D₁, D₂ and D₃ receptors (Ki values are 83, 13 and 0.71 nM, respectively). Shows significant affinity at α₂B and 5-HT₁A receptors (Ki values are 27 and 30 nM, respectively). Exhibits anti-Parkinsonian and antidepressant activity.
The product is subject to the following: Abcam Restricted Use Statement
Abcam GS 39783, GABAB positive allosteric modulator, 10MG
MW 337.4 Da, Purity >99%. Novel, GABAB positive allosteric modulator (EC50 = 3 μM for [35S]GTPγS binding). Shows anxiolytic and antiaddictive effects *in vivo.* Blood-brain barrier permeable*.* Orally active.
The product is subject to the following: Abcam Restricted Use Statement
Abcam (Arg8)-Vasopressin (AVP), Vasopressin receptor agonist, 1MG
MW 1084.2 Da, Purity >95%. (Arg8)-Vasopressin (AVP), Vasopressin receptor agonist. Achieve your results faster with highly validated, pure and trusted compounds.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Ibotenic acid, e x citoto x ic agonist, 1MG
MW 158.11 Da, Purity >98%. Neuroexcitatory amino acid originally isolated from Amanita species. Neurotoxin often used to model cognitive dysfunctions. NMDA and metabotropic receptor agonist.
The product is subject to the following: Abcam Restricted Use Statement
Chem-Impex International, Inc. Hemin (from porcine) | 16009-13-5 | MFCD00010726 | 1G
Hemin (from porcine), 16009-13-5, MFCD00010726, 1G
Chem-Impex International, Inc. Bilirubin | 635-65-4 | MFCD00005499 | 1G
Bilirubin, 635-65-4, MFCD00005499, 1G
Frontier Specialty Chemicals 5G PHTHALOCYANINE
This item has a minimum qty of 2 per supplier requirements.
Phthalocyanine; CAS No: 574-93-6
Strem, An Ascensus Company CAS# 16009-13-5. 5g. Hemin (Ferriprotoporphyrin IX chloride), min. 95%. MFCD00010726
CAS# 16009-13-5. 5g. Hemin (Ferriprotoporphyrin IX chloride), min. 95%. MFCD00010726. Molecular Weight: 651.95. Molecular Formula: Fe(C34H32N4O4)Cl. Color/form: black xtl. Strem# 26-1480. http://www.strem.com/catalog/v/26-1480/